NCT00242164View on ClinicalTrials.gov

Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

November 30, 2006

Conditions
Chronic Kidney DiseaseArrhythmia
Interventions
DRUG

Dialysate Magnesium (Concentration)

Trial Locations (2)

48104

University of Michigan Dialysis Center, Ann Arbor

48152

University of Michigan Dialysis Center, Livonia

All Listed Sponsors
collaborator

Renal Research Institute

OTHER

lead

University of Michigan

OTHER

NCT00242164 - Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis | Biotech Hunter | Biotech Hunter